Immuno Cure BioTech and PharmaJet are working together on a clinical study to test the effectiveness of PharmaJet’s ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Health authorities in Zambia have halted a planned clinical trial for an HIV vaccine after the United States withdrew funding ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Researchers have shown that a tiny nanoparticle formulation of saponin, along with an inflammation-promoting molecule called ...

By C.J. Atkins Just in time for Pride month, President Donald Trump and Health Secretary Robert F. Kennedy, Jr., have ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.